Evidence map›Paper›PMID 28126637›Full record

ArticleVirology2017

Characterization of contrasting features between hepatitis B virus genotype A and genotype D in small envelope protein expression and surface antigen secretion.

Fei Zhang, Xiaoli Tang, Tamako Garcia, Anna S Lok, Yongxiang Wang, Haodi Jia, Yanli Qin, Chaoyang Chen, Yumei Wen, Jisu Li and 1 more

Abstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fei ZhangKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Xiaoli TangLiver Research Center, Rhode Island Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Tamako GarciaLiver Research Center, Rhode Island Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Anna S LokDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
Yongxiang WangKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Haodi JiaKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Yanli QinDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Chaoyang ChenKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Yumei WenKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Jisu LiLiver Research Center, Rhode Island Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Shuping TongKey Lab of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China; Liver Research Center, Rhode Island Hospital, Warren Alpert School of Medicine, Brown University, Providence, RI, USA. Electronic address: shuping_tong_md@brown.edu.

Funding

Hepatitis B virus vaccine escape mutantsR01AI116639 · NIAID · RHODE ISLAND HOSPITAL · PI TONG, SHUPING · 2015 to 2019
$1.8M
Hepatitis B virus transcriptional interference and liver cancer-related mutationsR21AI113394 · NIAID · RHODE ISLAND HOSPITAL · PI TONG, SHUPING · 2015 to 2016
$443k
Hepatitis B virus genotypes B and CR21AI103648 · NIAID · RHODE ISLAND HOSPITAL · PI TONG, SHUPING · 2013 to 2014
$437k
Control of HBV replication at the step of core and P protein translationR21AI107618 · NIAID · RHODE ISLAND HOSPITAL · PI LI, JISU · 2013 to 2014
$423k
NIAID NIH HHS R01 AI116639NIAID NIH HHS R21 AI103648NIAID NIH HHS R21 AI107618NIAID NIH HHS R21 AI113394
6 · The paper itself

Abstract

Hepatitis B virus (HBV) genotypes A and D are prevalent in many parts of the world and show overlapping geographic distributions. We amplified the entire HBV genome from sera of patients with genotypes A and D and generated overlength constructs for transient transfection into Huh7 or HepG2 cells. Genotype D clones were associated with less HBsAg in culture supernatant and even less intracellular HBsAg. They produced less 2.1-kb RNA due to a weaker SPII promoter. Chimeric promoter constructs identified three divergent positions as most critical, and their exchange reversed extracellular HBsAg phenotype. The S protein of genotype D was more efficient at secretion, while its L protein possessed greater inhibitory effect. Swapping the S gene diminished genotypic difference in intracellular S protein but widened the difference in secreted HBsAg. In conclusion, HBV genotypes A and D differ in S protein expression, secretion and modulation by L protein.

Indexed as

Base SequenceCell Line, TumorGenotypeHepatitis B Surface AntigensHepatitis B virusHep G2 CellsHumansPromoter Regions, GeneticTranscription, GeneticViral Envelope ProteinsHepatitis B Surface AntigensL protein, hepatitis B virusViral Envelope ProteinsGenotypeHepatitis B surface antigenHepatitis B virusLarge envelope proteinSmall envelope proteinSPII promoter

Identifiers

PMID28126637
PMCPMC5325793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.